Cargando…
Effect of Diacerein on Metabolic Control and Inflammatory Markers in Patients with Type 2 Diabetes Using Antidiabetic Agents: A Randomized Controlled Trial
INTRODUCTION: Studies have shown that T2DM is an inflammatory disease. Thus, the present study was aimed at evaluating whether diacerein could improve the metabolic and inflammatory profile among patients with T2DM under long-term treatment with glucose-lowering agents. METHODS: This is a double-bli...
Autores principales: | Tres, Glaucia S., Fuchs, Sandra C., Piovesan, Fabiana, Koehler-Santos, Patricia, Pereira, Fernanda dos S., Camey, Suzi, Lisboa, Hugo K., Moreira, Leila B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5902058/ https://www.ncbi.nlm.nih.gov/pubmed/29805981 http://dx.doi.org/10.1155/2018/4246521 |
Ejemplares similares
-
Effect of diacerein on renal function and inflammatory cytokines in participants with type 2 diabetes mellitus and chronic kidney disease: A randomized controlled trial
por: Piovesan, Fabiana, et al.
Publicado: (2017) -
Topical diacerein for epidermolysis bullosa: a randomized controlled pilot study
por: Wally, Verena, et al.
Publicado: (2013) -
Diacerein treatment prevents colitis-associated cancer in mice
por: Paulino, Daiane S M, et al.
Publicado: (2020) -
Ion-pair compounds of diacerein for enhancing skin permeability in vitro: the compatibility–permeability relationship of counter ion and diacerein
por: Liang, Yan, et al.
Publicado: (2022) -
Postoperative efficacy of chondroprotectors and diacerein in dogs with osteoarthritis secondary to cranial cruciate ligament disease
por: Podestá, Florencia Sollier, et al.
Publicado: (2023)